Description

LL-37

Introduction

LL-37 is a premium-quality synthetic peptide manufactured using advanced peptide synthesis technology and stringent quality control procedures. LL-37 is a 37-amino-acid peptide derived from the human cathelicidin precursor protein (hCAP18) and is recognized as the only cathelicidin antimicrobial peptide naturally identified in humans. It is widely studied in scientific research for its unique molecular characteristics and role in innate immune biology.

Every production batch undergoes comprehensive analytical testing to verify identity, purity, and overall formulation consistency before release. Supplied as a lyophilized (freeze-dried) powder, LL-37 is carefully packaged to help maintain product integrity during storage, transportation, and handling.

Product Highlights

  • Premium-quality synthetic peptide
  • High-purity peptide formulation
  • 37-amino-acid peptide sequence
  • Advanced peptide synthesis technology
  • Lyophilized powder for enhanced stability
  • Batch-tested for quality and consistency
  • Manufactured under controlled production standards
  • Secure pharmaceutical-grade packaging

Product Specifications

Specification Details
Product Name LL-37
Category Synthetic Peptide
Peptide Type Cathelicidin-Derived Peptide
Amino Acid Length 37 Amino Acids
Form Lyophilized Powder
Appearance White to Off-White Powder
Purity High Purity (Batch Specific)
Packaging Sterile Glass Vial
Storage Store Refrigerated at 2°C–8°C

Manufacturing Excellence

LL-37 is manufactured using precision peptide synthesis followed by advanced purification techniques to maintain molecular integrity and formulation consistency. Every stage of production is carefully monitored to support dependable manufacturing quality and reliable batch performance.

Manufacturing focuses on:

  • Precision peptide synthesis
  • Advanced purification processes
  • Controlled production environments
  • Premium-quality raw materials
  • Consistent manufacturing standards
  • Reliable batch-to-batch production

Quality Assurance

Each production batch undergoes comprehensive analytical evaluation before release.

Quality testing includes:

  • Identity verification
  • Purity analysis
  • Appearance inspection
  • Stability assessment
  • Batch consistency evaluation
  • Packaging quality inspection

These procedures help maintain dependable manufacturing standards and consistent product quality.

Physical Characteristics

LL-37 is supplied as a lyophilized (freeze-dried) powder, providing excellent stability and dependable storage characteristics.

Typical characteristics include:

  • Fine white to off-white powder
  • Stable peptide composition
  • Moisture-protected packaging
  • Sterile glass vial presentation
  • Consistent product appearance

Packaging

Each vial is securely packaged to help preserve product quality during storage and transportation.

Packaging features include:

  • Sterile sealed glass vial
  • Tamper-evident seal
  • Product identification label
  • Batch number for traceability
  • Protective outer packaging

Storage Recommendations

For optimal product preservation:

  • Store refrigerated at 2°C–8°C.
  • Protect from direct sunlight.
  • Avoid excessive heat and humidity.
  • Keep the vial tightly sealed until use.
  • Store in the original packaging.
  • Do not use if the vial or packaging has been damaged.

Product Advantages

LL-37 is manufactured with an emphasis on precision, quality, and consistency.

Key advantages include:

  • High-purity peptide formulation
  • Advanced peptide synthesis technology
  • Reliable batch-to-batch consistency
  • Comprehensive analytical testing
  • Stable lyophilized formulation
  • Professional pharmaceutical-grade packaging
  • Controlled production standards
  • Excellent storage stability

Why Choose Premium Quality LL-37?

Premium-quality LL-37 is produced using carefully selected raw materials, advanced peptide synthesis technology, and comprehensive quality assurance procedures. Every stage of production is designed to maintain formulation consistency, product integrity, and dependable manufacturing quality from synthesis through final packaging.

Key quality commitments include:

  • Premium raw material selection
  • Advanced synthesis and purification techniques
  • Rigorous quality control
  • Consistent batch production
  • Secure pharmaceutical-grade packaging
  • Stable formulation for reliable storage